Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF APRIL 20, 2023 SAM #7814
SOLICITATION NOTICE

A -- DEVELOPMENT OF NOVEL NANOTHERAPEUTICS TO COMBAT PNEUMONIC PLAGUE

Notice Date
4/18/2023 10:36:56 AM
 
Notice Type
Presolicitation
 
NAICS
541380 — Testing Laboratories
 
Contracting Office
ARMY MED RES ACQ ACTIVITY FORT DETRICK MD 21702 USA
 
ZIP Code
21702
 
Solicitation Number
HT9425-23-DLH-0002
 
Response Due
5/4/2023 7:00:00 AM
 
Archive Date
05/05/2023
 
Point of Contact
Deborah Hagan, Tonya R. Kreps
 
E-Mail Address
Deborah.l.hagan.civ@health.mil, tonya.r.kreps.civ@health.mil
(Deborah.l.hagan.civ@health.mil, tonya.r.kreps.civ@health.mil)
 
Description
The Government has a requirement for the development of novel nanotherapeutic approaches targeting outer membrane proteins utilizing camelid single-domain antibodies and bovine-derived ultralong CDR3 antibody structures (e.g., BamA, LptD, and Ail) of virulent Yersinia pestis for the treatment of pneumonic plague for assessment in in vitro and in vivo assays. The Government intends to award an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for novel nanotherapeutic approaches targeting outer membrane proteins for the treatment of pneumonic plague (and potentially other infectious microbial organisms or toxins) for assessment in in vitro and in vivo assays support. These services include, but are not limited to production of high-quality recombinant proteins from bacteria, viruses, or toxins; vaccinating appropriate animal species (i.e. camelids and bovines) to generate the material needed to engineer completely novel nanotherapeutics; perform in vitro testing of nanotherapeutic characteristics in order to refine molecules and promote down-selection, provide material in sufficient quantity and appropriate quality for in vitro and in vivo studies (e.g. mice and non-human primates), engineer or formulate down-selected nanotherapeutics for different routes of administration in vivo (e.g., intramuscular or intravenous, etc.).
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/2a83a28772c948d98c671e550dacd7c0/view)
 
Place of Performance
Address: USA
Country: USA
 
Record
SN06653963-F 20230420/230418230121 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.